Literature DB >> 8499760

Prevalence of fractures in postmenopausal women with thyroid disease.

B L Solomon1, L Wartofsky, K D Burman.   

Abstract

We interviewed 300 white postmenopausal women (160 with thyroid disease, 140 without thyroid disease) to investigate whether having thyroid disease or taking thyroid hormone increased the prevalence of having a hip, vertebral, or forearm fracture. Thirty-seven (23%) women with thyroid disease and 45 (32%) women without thyroid disease had had a fracture, and there were no significant differences between these groups in the number or type of fractures. Dose of thyroid hormone and duration of therapy or disease did not affect fracture occurrence in women with thyroid disease. Women with a history of hyperthyroidism (9 of 32) or thyroid cancer (2 of 11) appeared to have their first fracture earlier (p < 0.01) than women without thyroid disease. In summary, women taking thyroid hormone for a variety of thyroid disorders do not appear to have an enhanced prevalence of a hip, vertebral, or forearm fractures, but women with a history of hyperthyroidism may have a propensity for their fractures to occur earlier in life.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8499760     DOI: 10.1089/thy.1993.3.17

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  7 in total

1.  New questions regarding bioequivalence of levothyroxine preparations: a clinician's response.

Authors:  William L Green
Journal:  AAPS J       Date:  2005-03-30       Impact factor: 4.009

2.  Role of chronic health disorders in perimenopausal fractures.

Authors:  Jukka Huopio; Risto Honkanen; Jukka Jurvelin; Seppo Saarikoski; Esko Alhava; Heikki Kröger
Journal:  Osteoporos Int       Date:  2005-03-01       Impact factor: 4.507

Review 3.  Adverse effects of thyroid hormones.

Authors:  J B Williams
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

4.  Papillary thyroid carcinoma is a risk factor for severe osteoporosis.

Authors:  Masakazu Notsu; Mika Yamauchi; Miwa Morita; Kiyoko Nawata; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2019-10-29       Impact factor: 2.626

5.  Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease.

Authors:  Monica A Ercolano; Monica L Drnovsek; Maria C Silva Croome; Monica Moos; Ana M Fuentes; Fanny Viale; Ulla Feldt-Rasmussen; Alicia T Gauna
Journal:  Thyroid Res       Date:  2013-09-11

6.  Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy.

Authors:  Eun Heui Kim; Yun Kyung Jeon; Kyoungjune Pak; In-Joo Kim; Seong-Jang Kim; Seunghyeon Shin; Bo Hyun Kim; Sang Soo Kim; Byung-Joo Lee; Jeong-Gyu Lee; Tae Sik Goh; Keunyoung Kim
Journal:  J Bone Metab       Date:  2019-02-28

Review 7.  Bone disease in thyrotoxicosis.

Authors:  P Amaresh Reddy; C V Harinarayan; Alok Sachan; V Suresh; G Rajagopal
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.